A human scFv antibody, named B1, showed a high affinity to an epitope (aa 1023–1189) on S2 protein. This antibody also showed potent neutralizing activities against SARS-CoV in vitro [50]. B1, 1F8 and 5E9 nAbs against epitopes on SARS-CoV S2 also showed effectiveness in neutralization [51].